Keratinocyte Growth Factor Modulates Alveolar Epithelial Cell Phenotype In Vitro: Expression of Aquaporin 5
We investigated the role of keratinocyte growth factor (KGF) in regulation of alveolar epithelial cell (AEC) phenotype in vitro. Effects of KGF on cell morphology, expression of surfactant apoproteins A, B, and C (SP-A, -B, and -C), and expression of aquaporin 5 (AQP5), a water channel present in si...
Gespeichert in:
Veröffentlicht in: | American journal of respiratory cell and molecular biology 1998-04, Vol.18 (4), p.554-561 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 561 |
---|---|
container_issue | 4 |
container_start_page | 554 |
container_title | American journal of respiratory cell and molecular biology |
container_volume | 18 |
creator | Borok, Zea Lubman, Richard L Danto, Spencer I Zhang, Xiao-Ling Zabski, Stephanie M King, Landon S Lee, Douglas M Agre, Peter Crandall, Edward D |
description | We investigated the role of keratinocyte growth factor (KGF) in regulation of alveolar epithelial cell (AEC) phenotype in vitro. Effects of KGF on cell morphology, expression of surfactant apoproteins A, B, and C (SP-A, -B, and -C), and expression of aquaporin 5 (AQP5), a water channel present in situ on the apical surface of alveolar type I (AT1) cells but not expressed in alveolar type II (AT2) cells, were evaluated in AECs grown in primary culture. Observations were made on AEC monolayers grown in serum-free medium without KGF (control) or grown continuously in the presence of KGF (10 ng/ml) from either Day 0 (i.e., the time of plating) or Day 4 or 6 through Day 8 in culture. AECs monolayers express AQP5 only on their apical surfaces as determined by cell surface biotinylation studies. Control AECs grown in the absence of KGF through Day 8 express increasing levels of AQP5, consistent with transition toward the AT1 cell phenotype. Exposure of AECs to KGF from Day 0 results in decreased AQP5 expression, retention of a cuboidal morphology, and greater numbers of lamellar bodies relative to control on Day 8 in culture. AECs treated with KGF from Day 4 or 6 exhibit a decrease in AQP5 expression through subsequent days in culture, as well as an increase in expression of surfactant apoproteins. These data, showing that KGF both prevents and reverses the increase in AQP5 (and decrease in surfactant apoprotein) expression that accompanies progression of the AT2 toward the AT1 cell phenotype, support the concepts that transdifferentiation between AT2 and AT1 cell phenotypes is at least partially reversible and that KGF may play a major role in modulating AEC phenotype. |
doi_str_mv | 10.1165/ajrcmb.18.4.2838 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79784573</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79784573</sourcerecordid><originalsourceid>FETCH-LOGICAL-c354t-1b03acb3087bb85b75ec5ae732b7936ed99ce7f3799bf60fe8626ff23431ccfd3</originalsourceid><addsrcrecordid>eNpdkUFv1DAQhS0EKm3hzgXJ4oC4ZLFjO7a5rVbbUlEEB-BqOd4J8eLEqe1Q9t83ZVccOM1I872np3kIvaJkRWkj3tt9ckO7omrFV7Vi6gk6p4KJimulny474byiguvn6CLnPSG0VpSeoTMtGNOcn6NfnyDZ4sfoDgXwdYr3pcdX1pWY8Oe4m4MtkPE6_IYYbMLbyZcegrcBbyAE_LWHMZbDBPhmxD98SfED3v6ZEuTs44hjh9d3s51i8iMWL9CzzoYML0_zEn2_2n7bfKxuv1zfbNa3lWOCl4q2hFnXMqJk2yrRSgFOWJCsbqVmDey0diA7JrVuu4Z0oJq66bqacUad63bsEr09-k4p3s2Qixl8dktcO0Kcs5FaKi4kW8A3_4H7OKdxyWZqIhvBG0YWiBwhl2LOCTozJT_YdDCUmMcSzLEEQ5Xh5rGERfL65Du3A-z-CU5fX-7vjvfe_-zvfQKTBxvCQtOT2V8vITh7ANvxkvM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>207654630</pqid></control><display><type>article</type><title>Keratinocyte Growth Factor Modulates Alveolar Epithelial Cell Phenotype In Vitro: Expression of Aquaporin 5</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Borok, Zea ; Lubman, Richard L ; Danto, Spencer I ; Zhang, Xiao-Ling ; Zabski, Stephanie M ; King, Landon S ; Lee, Douglas M ; Agre, Peter ; Crandall, Edward D</creator><creatorcontrib>Borok, Zea ; Lubman, Richard L ; Danto, Spencer I ; Zhang, Xiao-Ling ; Zabski, Stephanie M ; King, Landon S ; Lee, Douglas M ; Agre, Peter ; Crandall, Edward D</creatorcontrib><description>We investigated the role of keratinocyte growth factor (KGF) in regulation of alveolar epithelial cell (AEC) phenotype in vitro. Effects of KGF on cell morphology, expression of surfactant apoproteins A, B, and C (SP-A, -B, and -C), and expression of aquaporin 5 (AQP5), a water channel present in situ on the apical surface of alveolar type I (AT1) cells but not expressed in alveolar type II (AT2) cells, were evaluated in AECs grown in primary culture. Observations were made on AEC monolayers grown in serum-free medium without KGF (control) or grown continuously in the presence of KGF (10 ng/ml) from either Day 0 (i.e., the time of plating) or Day 4 or 6 through Day 8 in culture. AECs monolayers express AQP5 only on their apical surfaces as determined by cell surface biotinylation studies. Control AECs grown in the absence of KGF through Day 8 express increasing levels of AQP5, consistent with transition toward the AT1 cell phenotype. Exposure of AECs to KGF from Day 0 results in decreased AQP5 expression, retention of a cuboidal morphology, and greater numbers of lamellar bodies relative to control on Day 8 in culture. AECs treated with KGF from Day 4 or 6 exhibit a decrease in AQP5 expression through subsequent days in culture, as well as an increase in expression of surfactant apoproteins. These data, showing that KGF both prevents and reverses the increase in AQP5 (and decrease in surfactant apoprotein) expression that accompanies progression of the AT2 toward the AT1 cell phenotype, support the concepts that transdifferentiation between AT2 and AT1 cell phenotypes is at least partially reversible and that KGF may play a major role in modulating AEC phenotype.</description><identifier>ISSN: 1044-1549</identifier><identifier>EISSN: 1535-4989</identifier><identifier>DOI: 10.1165/ajrcmb.18.4.2838</identifier><identifier>PMID: 9533944</identifier><identifier>CODEN: AJRBEL</identifier><language>eng</language><publisher>United States: Am Thoracic Soc</publisher><subject>Animals ; Apoproteins - drug effects ; Apoproteins - genetics ; Aquaporin 5 ; Aquaporins ; Cell Polarity ; Cells, Cultured ; Epithelial Cells - classification ; Epithelial Cells - drug effects ; Epithelial Cells - metabolism ; Fibroblast Growth Factor 10 ; Fibroblast Growth Factor 7 ; Fibroblast Growth Factors ; Gene Expression - drug effects ; Gene Expression - genetics ; Growth Substances - pharmacology ; Ion Channels - analysis ; Ion Channels - drug effects ; Ion Channels - genetics ; Male ; Membrane Proteins ; Phenotype ; Protein Biosynthesis - drug effects ; Protein Biosynthesis - genetics ; Pulmonary Alveoli - cytology ; Pulmonary Alveoli - drug effects ; Pulmonary Surfactant-Associated Proteins ; Pulmonary Surfactants - drug effects ; Pulmonary Surfactants - genetics ; Rats ; Rats, Sprague-Dawley ; RNA, Messenger - analysis ; RNA, Messenger - drug effects ; RNA, Messenger - genetics ; Time Factors</subject><ispartof>American journal of respiratory cell and molecular biology, 1998-04, Vol.18 (4), p.554-561</ispartof><rights>Copyright American Lung Association Apr 1998</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c354t-1b03acb3087bb85b75ec5ae732b7936ed99ce7f3799bf60fe8626ff23431ccfd3</citedby><cites>FETCH-LOGICAL-c354t-1b03acb3087bb85b75ec5ae732b7936ed99ce7f3799bf60fe8626ff23431ccfd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9533944$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Borok, Zea</creatorcontrib><creatorcontrib>Lubman, Richard L</creatorcontrib><creatorcontrib>Danto, Spencer I</creatorcontrib><creatorcontrib>Zhang, Xiao-Ling</creatorcontrib><creatorcontrib>Zabski, Stephanie M</creatorcontrib><creatorcontrib>King, Landon S</creatorcontrib><creatorcontrib>Lee, Douglas M</creatorcontrib><creatorcontrib>Agre, Peter</creatorcontrib><creatorcontrib>Crandall, Edward D</creatorcontrib><title>Keratinocyte Growth Factor Modulates Alveolar Epithelial Cell Phenotype In Vitro: Expression of Aquaporin 5</title><title>American journal of respiratory cell and molecular biology</title><addtitle>Am J Respir Cell Mol Biol</addtitle><description>We investigated the role of keratinocyte growth factor (KGF) in regulation of alveolar epithelial cell (AEC) phenotype in vitro. Effects of KGF on cell morphology, expression of surfactant apoproteins A, B, and C (SP-A, -B, and -C), and expression of aquaporin 5 (AQP5), a water channel present in situ on the apical surface of alveolar type I (AT1) cells but not expressed in alveolar type II (AT2) cells, were evaluated in AECs grown in primary culture. Observations were made on AEC monolayers grown in serum-free medium without KGF (control) or grown continuously in the presence of KGF (10 ng/ml) from either Day 0 (i.e., the time of plating) or Day 4 or 6 through Day 8 in culture. AECs monolayers express AQP5 only on their apical surfaces as determined by cell surface biotinylation studies. Control AECs grown in the absence of KGF through Day 8 express increasing levels of AQP5, consistent with transition toward the AT1 cell phenotype. Exposure of AECs to KGF from Day 0 results in decreased AQP5 expression, retention of a cuboidal morphology, and greater numbers of lamellar bodies relative to control on Day 8 in culture. AECs treated with KGF from Day 4 or 6 exhibit a decrease in AQP5 expression through subsequent days in culture, as well as an increase in expression of surfactant apoproteins. These data, showing that KGF both prevents and reverses the increase in AQP5 (and decrease in surfactant apoprotein) expression that accompanies progression of the AT2 toward the AT1 cell phenotype, support the concepts that transdifferentiation between AT2 and AT1 cell phenotypes is at least partially reversible and that KGF may play a major role in modulating AEC phenotype.</description><subject>Animals</subject><subject>Apoproteins - drug effects</subject><subject>Apoproteins - genetics</subject><subject>Aquaporin 5</subject><subject>Aquaporins</subject><subject>Cell Polarity</subject><subject>Cells, Cultured</subject><subject>Epithelial Cells - classification</subject><subject>Epithelial Cells - drug effects</subject><subject>Epithelial Cells - metabolism</subject><subject>Fibroblast Growth Factor 10</subject><subject>Fibroblast Growth Factor 7</subject><subject>Fibroblast Growth Factors</subject><subject>Gene Expression - drug effects</subject><subject>Gene Expression - genetics</subject><subject>Growth Substances - pharmacology</subject><subject>Ion Channels - analysis</subject><subject>Ion Channels - drug effects</subject><subject>Ion Channels - genetics</subject><subject>Male</subject><subject>Membrane Proteins</subject><subject>Phenotype</subject><subject>Protein Biosynthesis - drug effects</subject><subject>Protein Biosynthesis - genetics</subject><subject>Pulmonary Alveoli - cytology</subject><subject>Pulmonary Alveoli - drug effects</subject><subject>Pulmonary Surfactant-Associated Proteins</subject><subject>Pulmonary Surfactants - drug effects</subject><subject>Pulmonary Surfactants - genetics</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>RNA, Messenger - analysis</subject><subject>RNA, Messenger - drug effects</subject><subject>RNA, Messenger - genetics</subject><subject>Time Factors</subject><issn>1044-1549</issn><issn>1535-4989</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpdkUFv1DAQhS0EKm3hzgXJ4oC4ZLFjO7a5rVbbUlEEB-BqOd4J8eLEqe1Q9t83ZVccOM1I872np3kIvaJkRWkj3tt9ckO7omrFV7Vi6gk6p4KJimulny474byiguvn6CLnPSG0VpSeoTMtGNOcn6NfnyDZ4sfoDgXwdYr3pcdX1pWY8Oe4m4MtkPE6_IYYbMLbyZcegrcBbyAE_LWHMZbDBPhmxD98SfED3v6ZEuTs44hjh9d3s51i8iMWL9CzzoYML0_zEn2_2n7bfKxuv1zfbNa3lWOCl4q2hFnXMqJk2yrRSgFOWJCsbqVmDey0diA7JrVuu4Z0oJq66bqacUad63bsEr09-k4p3s2Qixl8dktcO0Kcs5FaKi4kW8A3_4H7OKdxyWZqIhvBG0YWiBwhl2LOCTozJT_YdDCUmMcSzLEEQ5Xh5rGERfL65Du3A-z-CU5fX-7vjvfe_-zvfQKTBxvCQtOT2V8vITh7ANvxkvM</recordid><startdate>19980401</startdate><enddate>19980401</enddate><creator>Borok, Zea</creator><creator>Lubman, Richard L</creator><creator>Danto, Spencer I</creator><creator>Zhang, Xiao-Ling</creator><creator>Zabski, Stephanie M</creator><creator>King, Landon S</creator><creator>Lee, Douglas M</creator><creator>Agre, Peter</creator><creator>Crandall, Edward D</creator><general>Am Thoracic Soc</general><general>American Thoracic Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>19980401</creationdate><title>Keratinocyte Growth Factor Modulates Alveolar Epithelial Cell Phenotype In Vitro: Expression of Aquaporin 5</title><author>Borok, Zea ; Lubman, Richard L ; Danto, Spencer I ; Zhang, Xiao-Ling ; Zabski, Stephanie M ; King, Landon S ; Lee, Douglas M ; Agre, Peter ; Crandall, Edward D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c354t-1b03acb3087bb85b75ec5ae732b7936ed99ce7f3799bf60fe8626ff23431ccfd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Animals</topic><topic>Apoproteins - drug effects</topic><topic>Apoproteins - genetics</topic><topic>Aquaporin 5</topic><topic>Aquaporins</topic><topic>Cell Polarity</topic><topic>Cells, Cultured</topic><topic>Epithelial Cells - classification</topic><topic>Epithelial Cells - drug effects</topic><topic>Epithelial Cells - metabolism</topic><topic>Fibroblast Growth Factor 10</topic><topic>Fibroblast Growth Factor 7</topic><topic>Fibroblast Growth Factors</topic><topic>Gene Expression - drug effects</topic><topic>Gene Expression - genetics</topic><topic>Growth Substances - pharmacology</topic><topic>Ion Channels - analysis</topic><topic>Ion Channels - drug effects</topic><topic>Ion Channels - genetics</topic><topic>Male</topic><topic>Membrane Proteins</topic><topic>Phenotype</topic><topic>Protein Biosynthesis - drug effects</topic><topic>Protein Biosynthesis - genetics</topic><topic>Pulmonary Alveoli - cytology</topic><topic>Pulmonary Alveoli - drug effects</topic><topic>Pulmonary Surfactant-Associated Proteins</topic><topic>Pulmonary Surfactants - drug effects</topic><topic>Pulmonary Surfactants - genetics</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>RNA, Messenger - analysis</topic><topic>RNA, Messenger - drug effects</topic><topic>RNA, Messenger - genetics</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Borok, Zea</creatorcontrib><creatorcontrib>Lubman, Richard L</creatorcontrib><creatorcontrib>Danto, Spencer I</creatorcontrib><creatorcontrib>Zhang, Xiao-Ling</creatorcontrib><creatorcontrib>Zabski, Stephanie M</creatorcontrib><creatorcontrib>King, Landon S</creatorcontrib><creatorcontrib>Lee, Douglas M</creatorcontrib><creatorcontrib>Agre, Peter</creatorcontrib><creatorcontrib>Crandall, Edward D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of respiratory cell and molecular biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Borok, Zea</au><au>Lubman, Richard L</au><au>Danto, Spencer I</au><au>Zhang, Xiao-Ling</au><au>Zabski, Stephanie M</au><au>King, Landon S</au><au>Lee, Douglas M</au><au>Agre, Peter</au><au>Crandall, Edward D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Keratinocyte Growth Factor Modulates Alveolar Epithelial Cell Phenotype In Vitro: Expression of Aquaporin 5</atitle><jtitle>American journal of respiratory cell and molecular biology</jtitle><addtitle>Am J Respir Cell Mol Biol</addtitle><date>1998-04-01</date><risdate>1998</risdate><volume>18</volume><issue>4</issue><spage>554</spage><epage>561</epage><pages>554-561</pages><issn>1044-1549</issn><eissn>1535-4989</eissn><coden>AJRBEL</coden><abstract>We investigated the role of keratinocyte growth factor (KGF) in regulation of alveolar epithelial cell (AEC) phenotype in vitro. Effects of KGF on cell morphology, expression of surfactant apoproteins A, B, and C (SP-A, -B, and -C), and expression of aquaporin 5 (AQP5), a water channel present in situ on the apical surface of alveolar type I (AT1) cells but not expressed in alveolar type II (AT2) cells, were evaluated in AECs grown in primary culture. Observations were made on AEC monolayers grown in serum-free medium without KGF (control) or grown continuously in the presence of KGF (10 ng/ml) from either Day 0 (i.e., the time of plating) or Day 4 or 6 through Day 8 in culture. AECs monolayers express AQP5 only on their apical surfaces as determined by cell surface biotinylation studies. Control AECs grown in the absence of KGF through Day 8 express increasing levels of AQP5, consistent with transition toward the AT1 cell phenotype. Exposure of AECs to KGF from Day 0 results in decreased AQP5 expression, retention of a cuboidal morphology, and greater numbers of lamellar bodies relative to control on Day 8 in culture. AECs treated with KGF from Day 4 or 6 exhibit a decrease in AQP5 expression through subsequent days in culture, as well as an increase in expression of surfactant apoproteins. These data, showing that KGF both prevents and reverses the increase in AQP5 (and decrease in surfactant apoprotein) expression that accompanies progression of the AT2 toward the AT1 cell phenotype, support the concepts that transdifferentiation between AT2 and AT1 cell phenotypes is at least partially reversible and that KGF may play a major role in modulating AEC phenotype.</abstract><cop>United States</cop><pub>Am Thoracic Soc</pub><pmid>9533944</pmid><doi>10.1165/ajrcmb.18.4.2838</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1044-1549 |
ispartof | American journal of respiratory cell and molecular biology, 1998-04, Vol.18 (4), p.554-561 |
issn | 1044-1549 1535-4989 |
language | eng |
recordid | cdi_proquest_miscellaneous_79784573 |
source | MEDLINE; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Animals Apoproteins - drug effects Apoproteins - genetics Aquaporin 5 Aquaporins Cell Polarity Cells, Cultured Epithelial Cells - classification Epithelial Cells - drug effects Epithelial Cells - metabolism Fibroblast Growth Factor 10 Fibroblast Growth Factor 7 Fibroblast Growth Factors Gene Expression - drug effects Gene Expression - genetics Growth Substances - pharmacology Ion Channels - analysis Ion Channels - drug effects Ion Channels - genetics Male Membrane Proteins Phenotype Protein Biosynthesis - drug effects Protein Biosynthesis - genetics Pulmonary Alveoli - cytology Pulmonary Alveoli - drug effects Pulmonary Surfactant-Associated Proteins Pulmonary Surfactants - drug effects Pulmonary Surfactants - genetics Rats Rats, Sprague-Dawley RNA, Messenger - analysis RNA, Messenger - drug effects RNA, Messenger - genetics Time Factors |
title | Keratinocyte Growth Factor Modulates Alveolar Epithelial Cell Phenotype In Vitro: Expression of Aquaporin 5 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T10%3A37%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Keratinocyte%20Growth%20Factor%20Modulates%20Alveolar%20Epithelial%20Cell%20Phenotype%20In%20Vitro:%20Expression%20of%20Aquaporin%205&rft.jtitle=American%20journal%20of%20respiratory%20cell%20and%20molecular%20biology&rft.au=Borok,%20Zea&rft.date=1998-04-01&rft.volume=18&rft.issue=4&rft.spage=554&rft.epage=561&rft.pages=554-561&rft.issn=1044-1549&rft.eissn=1535-4989&rft.coden=AJRBEL&rft_id=info:doi/10.1165/ajrcmb.18.4.2838&rft_dat=%3Cproquest_cross%3E79784573%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=207654630&rft_id=info:pmid/9533944&rfr_iscdi=true |